NHS Adoption Guide for Digital Health Founders

Get in touch

FREE RESOURCE

A free practical guide to the product, architecture, evidence and commercial decisions behind NHS adoption. Written by ULAM LABS and RBIL.

iPad showing the ebook cover: Build Digital Health Products the NHS Can Actually Adopt
Free resource

Build Digital Health Products the NHS Can Actually Adopt

A practical guide to the product, architecture, evidence and commercial decisions that decide whether an NHS organisation can buy your product. Written for teams at the point where the product works, and deals with everything that has to be true before the NHS can use it.

  • See why products that win in private care stall at NHS adoption
  • Design architecture that survives your second Trust, not just your first
  • Collect the evidence procurement asks for - from the start of your pilot
After you read it

What this guide is actually for

  • Plan your roadmap around what NHS adoption actually requires, not what you'll find out during procurement.

  • Agree the architecture decisions with your team that a second Trust won't force you to redo.

  • Separate the requirements that genuinely block adoption from the ones that can wait a release.

  • Walk into conversations with Trusts, ICBs and investors with the right answers already prepared.

Who it's for

Written for the stage you're at

  • Market entry

    You have traction, but not in the NHS

    Your product performs in private clinics, D2C or another health system, and NHS conversations keep stalling somewhere between information governance, the business case and the pathway.

    1
  • MVP to pilot

    Your MVP works, but wasn't designed for a Trust

    Single‑tenant, three roles, no audit trail, hosting outside the UK - decisions that were reasonable at MVP stage and become expensive once a second Trust says yes.

    2
  • Pilot running

    You're collecting the wrong evidence

    Your first deployment is running, and nobody agreed upfront which outcome measures the finance director, the clinical team and the commissioner each need to see.

    3
  • Fundraising

    You need an NHS story for your next raise

    Investors want proof of a route to NHS revenue, not a demo and a letter of intent.

    4
About author

Rafał Nowicki

CTO at ULAM LABS

Rafał has spent 8 years building HIPAA-compliant healthcare systems, including EHR platforms serving 200+ hospitals. He specializes in security architecture and regulatory compliance for HealthTech companies navigating FDA and HIPAA requirements.

Rafał Nowicki, CTO at ULAM LABS
About author

Richard Booth PhD

Director at RBI

Helps health organisations and innovators get proven technologies into practice. He has worked on this problem from both within and outside the system with roles inside NHS England on national innovation policy, at a digital healthtech company deploying products into clinical sites, and most recently as Deputy CEO of a Health Innovation Network.

Richard Booth PhD, Director at RBI
FAQ

Frequently asked questions

Is this only relevant to UK companies?

No, a large part of it is written for teams entering the NHS from another market, where a proposition that works elsewhere needs rebuilding for how the NHS commissions, funds and adopts.

Is it technical?

Parts 3 and 4 are written for CTOs and engineering leads. Parts 1, 2 and 5 are written for founders and commercial leads. Most teams read it together.

Let's see if we're a good fit

No lengthy onboarding, no big commitment upfront. Book a call and we'll tell you within a week if we're the right fit.

Book a discovery call
About us